Spectral Medical announced the retirement of their executive vice president and chief financial officer, Tony Businskas, will be retiring at the start of 2018.
Spectral Medical (TSX:EDT) announced the retirement of their executive vice president and chief financial officer, Tony Businskas, will be retiring at the start of 2018.
As quoted in the press release:
Tony joined Spectral in 2005 from his role as a senior VP and CFO for MDS Pharma Services and quickly became an important and key member of the senior management team. Tony’s oversight of the Company’s financial reporting and controls, as well as his leadership and guidance through many years of successful financings, third party license negotiations and operations, has been invaluable in setting the Company up for continued success.
Dr. Paul Walker, the Chief Executive Officer of Spectral commented, “Tony has been a tremendous asset to the Spectral vision of creating a unique theranostic company. His relentless hard work has helped pave the way for our ongoing efforts for FDA approval of a targeted treatment for patients with septic shock. The Board of Directors joins me in sincerely thanking Tony for his many years of dedicated work and wish him the best for a well-deserved retirement.”